Biotech Archives - Page 740 of 795

1 minute read

FDA
News

FDA Alerts Patients, Caregivers, And Health Care Providers Of Cross-Compatibility Issues With Autoinjector Devices That Are Optional For Use With Glatiramer Acetate Injection

August 18, 8:59 AM

Received Reports That Using Autoinjector Not Compatible With Specific Glatiramer Acetate Injection Drug Product Resulted In Missed, Partial Doses

TEVA

1 minute read

BridgeBio Starts Dosing In Early-Stage Genetic Metabolism Disorder Trial

By Vandana Singh

August 18, 8:53 AM

BridgeBio Pharma Inc (NASDAQ:BBIO) has dosed the first patient in its Phase 1 trial of BBP-671, an investigational oral therapy for…

BBIO

1 minute read

FDA Clears Curis’ Lymphoma Study, Keeping Leukemia Trial Still Stalled

By Vandana Singh

August 18, 8:49 AM

The FDA has lifted the partial clinical hold on Curis Inc’s (NASDAQ:CRIS) TakeAim Lymphoma Phase 1/2 study of emavusertib after reviewing the…

CRIS

1 minute read

ABVC BioPharma Says Phase II Vitargus Clinical Trial Receives Local Ethics Committee Approval In Thailand

By Benzinga Newsdesk

August 18, 8:33 AM

ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that, on August 2, 2022, approval was

ABVC

1 minute read

Arcturus Reports Durability Data Against Omicron Variants, Including BA.5, At Six-Month Timepoint Following Booster With ARCT-154 COVID-19 Vaccine

By Benzinga Newsdesk

August 18, 8:02 AM

New clinical data demonstrate high and sustained geometric mean fold rises (GMFR) in neutralizing antibodies against all evaluated Omicron variants Six months after booster dose of ARCT-154: BA.1: GMFR = 22 to 52;

ARCT

2 minute read

Science 37 And Syapse Partner To Enable Faster Patient Enrollment In Oncology Clinical Trials

By Benzinga Newsdesk

August 18, 7:55 AM

Science 37 Holdings, Inc. (NASDAQ:SNCE), the Agile Clinical Trial Operating System™, and Syapse®, a leading real-world evidence company, today announced a partnership to deploy proprietary real-world data

SNCE

2 minute read

Jazz Pharmaceuticals Announces Initiation Of Phase 3 Trial Evaluating Epidiolex/Epidyolex For Patients With Epilepsy With Myoclonic-Atonic Seizures

By Bill Haddad

August 18, 7:32 AM

Trial is the first randomized, controlled clinical trial evaluating cannabidiol to treat children and adolescents living with a developmental and epileptic encephalopathy known as Epilepsy with

JAZZ

2 minute read

BioCryst Announces Approval Of ORLADEYO In Saudi Arabia

By Benzinga Newsdesk

August 18, 7:12 AM

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Saudi Food and Drug Authority (SFDA) has approved oral, once-daily ORLADEYO® (berotralstat) to prevent attacks of hereditary

BCRX

2 minute read

BD Launches First-in-Human Trial Of Sirolimus Drug-Coated Balloon To Expand Treatment Options For Peripheral Arterial Disease

By Benzinga Newsdesk

August 18, 6:36 AM

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, has announced the start of enrollment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). BD is a

BDX

2 minute read

Why This Analyst Sees A 51% Return On This Cathie Wood-Favored Biotech Stock

By AJ Fabino

August 17, 6:33 PM

Biotech stocks have the potential for huge gains if a product or drug is deemed effective and safe, but investing in the shares of those companies can be volatile.

ARKK